WALTHAM, Mass.--(BUSINESS WIRE)--Phase Forward (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, today announced contract research organization (CRO) Veristat and submissions leader ISI have selected its Web Submission Data Manager (WebSDM™) application to help their clients submit CDISC SDTM-compliant data to the U.S. Food and Drug Administration (FDA). Phase Forward developed the WebSDM application in cooperation with the FDA, where it has been in use since 2004. Veristat’s and ISI’s adoption of the WebSDM software marks an expansion of the companies’ relationship with Phase Forward in response to client demand. Phase Forward has a longstanding commitment to ensuring its products are attractive to these industry segments. Many of its CRO clients, for example, utilize multiple Phase Forward products.
